Recognition of Stanford Ophthalmology Faculty

2020 is a special year for ophthalmology, one in which we recognize our aspiration for 20/20 vision and celebrate the inspiring work of the Byers Eye Institute faculty for their cutting-edge research and innovative patient-centered care.

COVID-19 has overshadowed almost everything in 2020, so we want to pause to celebrate some good news. Four of our Stanford ophthalmology faculty were recently selected as the world’s top 100 "most influential figures in ophthalmology!” in The Ophthalmologist, 2020 Power List. To our knowledge, more Stanford Ophthalmology faculty were selected to the top 100 in 2020 than from any other institution.

Join us in celebrating Drs. Jeffrey Goldberg, Geoffrey Tabin, Kuldev Singh, and Daniel Palanker – all selected for their tremendous contributions to the field of ophthalmology.  Selection to the 2020 Power List is a tribute to their life-changing impact on eye disease across the globe. Read on about these world leaders in ophthalmology.

Jeffrey Goldberg, MD, PhD – Blumenkranz Smead Professor and Chair of the Department of Ophthalmology, Stanford University

As department chair, Dr. Jeff Goldberg has developed an expansive dynamic vision research program across all eye diseases at Stanford. He is a world leader in the neuroprotection and regeneration of retinal ganglion cells and the optic nerve, a major unmet need in glaucoma and other optic neuropathies, and his research includes novel stem cell and nanotherapeutic approaches. He recently received FDA approval to expand the only US phase two clinical trial to test the neuroprotective and regenerative effects of neurotrophic factors on glaucoma, with the goal of preserving vision. His clinical focus is glaucoma and other retinal and optic nerve diseases, as well as cataract.

Geoffrey Tabin, MD – Fairweather Foundation Professor of Ophthalmology, Stanford University

Dr. Tabin was also featured in the Power List last year as a Champion of Change.

Dr. Geoff Tabin is the Director of Stanford’s Global Ophthalmology Program. He co-founded the Himalayan Cataract Project with Dr. Sanduk Ruit in 1995 with a goal to eradicate cataract related blindness in the Himalayas. Together they achieved this remarkable feat and implemented a well-functioning healthcare infrastructure for the delivery of high quality eye care. Dr. Tabin has dedicated the last 10 years to tackling the desperate lack of eye care and the high incidence of blindness in Sub-Saharan Africa where he is working to build sustainable eye care delivery. He is also researching the applicability of international approaches to developing low-cost solutions for eye care delivery in underserved U.S. communities. Dr. Tabin has been recognized as a world leader and visionary in global health.

Daniel Palanker, PhD – Professor of Ophthalmology, and, by courtesy, of Electrical Engineering

Dr. Palanker is Director of the Hansen Experimental Physics Laboratory. He works on optical and electronic technologies for diagnostic, therapeutic, surgical and prosthetic applications in ophthalmology. Dr. Palanker has developed a wireless retinal prosthesis to restore sight in patients blinded by age-related macular degeneration, achieving the highest visual acuity to date. Dr. Palanker’s team is now developing a second generation microchip to replace damaged photoreceptor cells to achieve even greater capacity for patients to see. His other research includes non-damaging retinal laser therapy and use of ultrafast lasers for ocular surgery. He holds numerous patents for his inventions, many of which are widely used vision preserving treatments for patients with a variety of eye diseases.

Kuldev Singh, MD, MPH – Professor of Ophthalmology

Dr. Kuldev Singh is the Director of the Glaucoma Service and the Glaucoma Fellowship Program and is a renowned glaucoma surgeon. His current research interests include glaucoma and cataract surgical trials, the epidemiology of myopia and glaucoma, ophthalmic genetics as well as health care delivery in underserved communities in the United States and overseas. Dr. Singh's clinical practice focuses on the medical, laser and surgical management of glaucoma and cataract. Dr. Singh has served as the President of the American Glaucoma Society and as Executive Vice President of the World Glaucoma Association. He is also the recipient of the Lifetime Achievement Honor Award from the American Academy of Ophthalmology.

To learn more about Stanford’s ophthalmology program and how you can support its life-changing work, or about any of Stanford ophthalmology’s renowned faculty, please contact Melanie or Bob:

Stanford University
Medical Center Development
Mobile: 650-269-4251

Stanford University
Medical Center Development
Mobile: 650-223-9121